2022 Q1 Form 10-Q Financial Statement

#000156459022019879 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.957M $6.504M $8.430M
YoY Change -29.34% -9.29% -3.44%
% of Gross Profit
Research & Development $17.21M $14.75M $18.55M
YoY Change -7.27% -55.99% -19.51%
% of Gross Profit
Depreciation & Amortization $120.0K $120.0K $107.0K
YoY Change 12.15% -61.29% -6.96%
% of Gross Profit
Operating Expenses $23.16M $21.25M $27.26M
YoY Change -15.03% -47.76% -14.22%
Operating Profit -$23.16M -$27.26M
YoY Change -15.03% -1.57%
Interest Expense $71.00K $101.0K $60.00K
YoY Change 18.33% -54.09% -94.23%
% of Operating Profit
Other Income/Expense, Net $71.00K $58.00K
YoY Change 22.41% -94.42%
Pretax Income -$23.09M -$62.79M -$27.20M
YoY Change -15.11% 59.28% 2.04%
Income Tax -$2.531M
% Of Pretax Income
Net Earnings -$23.09M -$60.26M -$27.20M
YoY Change -15.11% 52.87% 2.04%
Net Earnings / Revenue
Basic Earnings Per Share -$0.48
Diluted Earnings Per Share -$479.8K -$1.341M -$685.5K
COMMON SHARES
Basic Shares Outstanding 48.12M
Diluted Shares Outstanding 48.12M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $123.0M $146.6M $214.9M
YoY Change -42.76% -32.25% -13.74%
Cash & Equivalents $51.17M $45.63M $78.25M
Short-Term Investments $71.83M $101.0M $136.6M
Other Short-Term Assets $7.253M $7.241M $6.500M
YoY Change 11.58% 4.94% 41.3%
Inventory
Prepaid Expenses
Receivables $524.0K $336.0K $200.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $130.8M $154.2M $221.6M
YoY Change -40.99% -31.31% -13.69%
LONG-TERM ASSETS
Property, Plant & Equipment $6.319M $1.139M $9.600M
YoY Change -34.18% -28.81% 439.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $23.46M $27.97M
YoY Change
Other Assets $2.175M $1.703M $6.000M
YoY Change -63.75% -73.36% 261.23%
Total Long-Term Assets $31.95M $36.86M $57.30M
YoY Change -44.24% -37.28% 1.31%
TOTAL ASSETS
Total Short-Term Assets $130.8M $154.2M $221.6M
Total Long-Term Assets $31.95M $36.86M $57.30M
Total Assets $162.7M $191.1M $278.9M
YoY Change -41.65% -32.55% -10.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.407M $2.659M $3.600M
YoY Change -60.92% -42.17% 71.1%
Accrued Expenses $2.499M $6.863M $3.659M
YoY Change -31.7% -42.75% -17.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.71M $16.07M $14.50M
YoY Change -26.14% -34.22% -31.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.230M $6.058M $14.60M
YoY Change -64.18% -61.41% -61.48%
Total Long-Term Liabilities $5.230M $6.058M $14.60M
YoY Change -64.18% -61.41% -61.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.71M $16.07M $14.50M
Total Long-Term Liabilities $5.230M $6.058M $14.60M
Total Liabilities $15.94M $22.13M $31.70M
YoY Change -49.72% -48.14% -48.49%
SHAREHOLDERS EQUITY
Retained Earnings -$654.5M -$631.4M
YoY Change 25.89%
Common Stock $802.2M $800.8M
YoY Change 7.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $146.8M $168.9M $247.2M
YoY Change
Total Liabilities & Shareholders Equity $162.7M $191.1M $278.9M
YoY Change -41.65% -32.55% -10.98%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$23.09M -$60.26M -$27.20M
YoY Change -15.11% 52.87% 2.04%
Depreciation, Depletion And Amortization $120.0K $120.0K $107.0K
YoY Change 12.15% -61.29% -6.96%
Cash From Operating Activities -$27.50M -$19.36M -$33.34M
YoY Change -17.52% -23.38% 32.22%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$18.00K $3.078M
YoY Change -100.0% -98.97% 4635.38%
Acquisitions
YoY Change
Other Investing Activities $33.05M -$8.466M $21.09M
YoY Change 56.7% -137.69% 1.59%
Cash From Investing Activities $33.05M -$8.484M $18.02M
YoY Change 83.44% -140.97% -12.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $34.14M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 2.713M 34.14M
YoY Change -100.0% -52.32% 28586.55%
NET CHANGE
Cash From Operating Activities -27.50M -19.36M -33.34M
Cash From Investing Activities 33.05M -8.484M 18.02M
Cash From Financing Activities 0.000 2.713M 34.14M
Net Change In Cash -27.50M -25.13M 18.81M
YoY Change -246.22% -2324.16% -526.9%
FREE CASH FLOW
Cash From Operating Activities -$27.50M -$19.36M -$33.34M
Capital Expenditures $0.00 -$18.00K $3.078M
Free Cash Flow -$27.50M -$19.34M -$36.42M
YoY Change -24.49% -17.76% 44.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6863000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3207000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3151000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10709000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48132937
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48132937
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48120437
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16073000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2733000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48120437
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
48000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
48000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
802170000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
800728000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-908000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-419000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-654519000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-631428000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
146791000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
168929000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2733000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2497000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3325000
CY2022Q1 us-gaap Liabilities
Liabilities
15939000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
27972000
CY2022Q1 us-gaap Assets
Assets
162730000
CY2021Q4 us-gaap Assets
Assets
191060000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1407000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2659000
CY2022Q1 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
3596000
CY2021Q4 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
3400000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2499000
CY2021Q4 us-gaap Liabilities
Liabilities
22131000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
162730000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
191060000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17205000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18554000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5957000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8704000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
23162000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
27258000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23162000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-27258000
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
71000
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
58000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
71000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
58000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23091000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-27200000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-489000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23580000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27201000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48123930
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39679734
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
168929000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-489000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1442000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
146791000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
240578000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34137000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-270000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-27200000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
247244000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-23091000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-27200000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1443000
CY2022Q1 asmb Amortization Of Investments In Marketable Debt Securities
AmortizationOfInvestmentsInMarketableDebtSecurities
-149000
CY2021Q1 asmb Amortization Of Investments In Marketable Debt Securities
AmortizationOfInvestmentsInMarketableDebtSecurities
-92000
CY2022Q1 asmb Noncash Rent Expense
NoncashRentExpense
893000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1611000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1027000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-303000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-358000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1036000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2022Q1 asmb Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
196000
CY2021Q1 asmb Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
-102000
CY2021Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-8312000
CY2022Q1 asmb Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-923000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27502000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
857000
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49213000
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
66450000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3000000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18016000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 asmb Number Of Approved Products
NumberOfApprovedProducts
0
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include estimates of costs incurred but not yet invoiced for research and development accruals, recoverability and useful lives of our long-lived assets, amounts receivable under collaboration agreements, measurement of operating lease liabilities, and the fair value of stock options, stock appreciation rights, and RSUs granted to employees, directors, and consultants.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible these external factors could have an effect on the Company’s estimates and could cause actual results to differ materially from those estimates and assumptions.</p>
CY2022Q1 asmb Capitalized And Amortized Costs Period
CapitalizedAndAmortizedCostsPeriod
P5Y
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23091000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-27200000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48123930
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39679734
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9158738
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8093959
CY2022Q1 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Amortized Cost
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesAmortizedCost
144281000
CY2022Q1 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Gain
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedGain
0
CY2022Q1 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Loss
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedLoss
635000
CY2022Q1 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Estimated Fair Value
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesEstimatedFairValue
143646000
CY2021Q4 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Amortized Cost
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesAmortizedCost
171625000
CY2021Q4 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Gain
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedGain
0
CY2021Q4 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Loss
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedLoss
146000
CY2021Q4 asmb Cash Equivalents At Carrying Value And Available For Sale Debt Securities Estimated Fair Value
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesEstimatedFairValue
171479000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
437000
CY2022Q1 asmb Fair Value Assets Between Levels Transfers Amount
FairValueAssetsBetweenLevelsTransfersAmount
0
CY2021Q4 asmb Fair Value Assets Between Levels Transfers Amount
FairValueAssetsBetweenLevelsTransfersAmount
0
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2161000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6426000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
338000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2499000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6863000
CY2020Q3 asmb Initial Public Offering Value Of Shares Authorized
InitialPublicOfferingValueOfSharesAuthorized
300000000.0
CY2020Q3 asmb Initial Public Offering Value Of Shares Authorized
InitialPublicOfferingValueOfSharesAuthorized
300000000.0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6600000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.63
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.15
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1443000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-286000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
10900000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2022Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
800000
CY2022Q1 asmb Milestone Payment Diligence Maintenance Fees
MilestonePaymentDiligenceMaintenanceFees
100000
CY2021Q1 asmb Milestone Payment Diligence Maintenance Fees
MilestonePaymentDiligenceMaintenanceFees
0

Files In Submission

Name View Source Status
0001564590-22-019879-index-headers.html Edgar Link pending
0001564590-22-019879-index.html Edgar Link pending
0001564590-22-019879.txt Edgar Link pending
0001564590-22-019879-xbrl.zip Edgar Link pending
asmb-10q_20220331.htm Edgar Link pending
asmb-10q_20220331_htm.xml Edgar Link completed
asmb-20220331.xsd Edgar Link pending
asmb-20220331_cal.xml Edgar Link unprocessable
asmb-20220331_def.xml Edgar Link unprocessable
asmb-20220331_lab.xml Edgar Link unprocessable
asmb-20220331_pre.xml Edgar Link unprocessable
asmb-ex311_7.htm Edgar Link pending
asmb-ex312_8.htm Edgar Link pending
asmb-ex321_9.htm Edgar Link pending
asmb-ex322_11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending